BioTime, Inc. today announced that it has entered into a collaboration with Susan Thibeault, Ph.D., of the University of Wisconsin and Marc Remacle, M.D. of Louvain University to evaluate BioTime's proprietary HyStem A -based hydrogel for the treatment of vocal fold scarring.
http://ift.tt/VPTRbJ
http://ift.tt/VPTRbJ
No comments:
Post a Comment